CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:One-carbon unit supplementation fuels purine synthesis in tumor-infiltrating T cells and augments checkpoint blockade.
One-carbon unit supplementation fuels purine synthesis in tumor-infiltrating T cells and augments checkpoint blockade.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
核苷酸执行重要的代谢功能,携带能量并供给核酸合成。在此,我们使用同位素示踪-质谱法来定量补救合成与从头合成对嘌呤核苷酸的贡献。我们进一步探索了增加嘌呤合成关键前体——一碳(1C)单元的影响。我们发现肿瘤和肿瘤浸润T细胞(相对于脾脏或淋巴结T细胞)通过从头合成途径合成嘌呤。因此,T细胞嘌呤合成所需1C单元的短缺是抗肿瘤免疫的潜在瓶颈。通过输注甲酸盐补充1C单元,可驱动甲酸盐在肿瘤浸润T细胞中同化进入嘌呤。口服给予甲醇可作为甲酸盐前药,氘代化可实现甲酸盐生成的动力学控制。安全剂量的甲醇提高甲酸盐水平并增强MC38肿瘤中抗PD-1检查点阻断的疗效,使持久缓解率增至三倍。因此,1C缺乏可限制抗肿瘤免疫,而这一代谢检查点可通过药理学1C补充来克服。
Nucleotides perform important metabolic functions, carrying energy and feeding nucleic acid synthesis.
Here, we use isotope tracing-mass spectrometry to quantitate contributions to purine nucleotides from salvage versus de novo synthesis.
We further explore the impact of augmenting a key precursor for purine synthesis, one-carbon (1C) units.
We show that tumors and tumor-infiltrating T cells (relative to splenic or lymph node T cells) synthesize purines de novo. Shortage of 1C units for T cell purine synthesis is accordingly a potential bottleneck for anti-tumor immunity. Supplementing 1C units by infusing formate drives formate assimilation into purines in tumor-infiltrating T cells.
Orally administered methanol functions as a formate pro-drug, with deuteration enabling kinetic control of formate production. Safe doses of methanol raise formate levels and augment anti-PD-1 checkpoint blockade in MC38 tumors, tripling durable regressions.
Thus, 1C deficiency can gate antitumor immunity and this metabolic checkpoint can be overcome with pharmacological 1C supplementation.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。